NO912970L - Fremgangsmaate for fremstilling av derivater av n-sylfonylindolin. - Google Patents

Fremgangsmaate for fremstilling av derivater av n-sylfonylindolin.

Info

Publication number
NO912970L
NO912970L NO91912970A NO912970A NO912970L NO 912970 L NO912970 L NO 912970L NO 91912970 A NO91912970 A NO 91912970A NO 912970 A NO912970 A NO 912970A NO 912970 L NO912970 L NO 912970L
Authority
NO
Norway
Prior art keywords
denotes
alkyl
group
trifluoromethyl
naphthyl
Prior art date
Application number
NO91912970A
Other languages
English (en)
Other versions
NO912970D0 (no
NO175254C (no
NO175254B (no
Inventor
Jean Wagon
Paul De Cointet
Dino Nisato
Claude Plouzane
Claudine Serradeil-Legal
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO912970D0 publication Critical patent/NO912970D0/no
Publication of NO912970L publication Critical patent/NO912970L/no
Publication of NO175254B publication Critical patent/NO175254B/no
Publication of NO175254C publication Critical patent/NO175254C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO912970A 1990-07-31 1991-07-30 Analogifremgangsmåte for fremstilling av terapeutisk aktive derivater av N-sulfonylindolin NO175254C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9009778A FR2665441B1 (fr) 1990-07-31 1990-07-31 Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant.

Publications (4)

Publication Number Publication Date
NO912970D0 NO912970D0 (no) 1991-07-30
NO912970L true NO912970L (no) 1992-02-03
NO175254B NO175254B (no) 1994-06-13
NO175254C NO175254C (no) 1994-09-21

Family

ID=9399281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912970A NO175254C (no) 1990-07-31 1991-07-30 Analogifremgangsmåte for fremstilling av terapeutisk aktive derivater av N-sulfonylindolin

Country Status (17)

Country Link
EP (1) EP0469984B1 (no)
JP (1) JP3195381B2 (no)
KR (1) KR100211434B1 (no)
AT (1) ATE129236T1 (no)
AU (2) AU645585B2 (no)
CA (1) CA2048139C (no)
DE (1) DE69113911T2 (no)
ES (1) ES2080922T3 (no)
FI (1) FI97224C (no)
FR (1) FR2665441B1 (no)
HU (1) HU220765B1 (no)
IE (1) IE73452B1 (no)
IL (2) IL99012A (no)
NO (1) NO175254C (no)
NZ (1) NZ239182A (no)
PT (1) PT98476B (no)
ZA (1) ZA916031B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5481005A (en) * 1990-07-31 1996-01-02 Sanofi N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
US5338755A (en) * 1990-07-31 1994-08-16 Elf Sanofi N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
EP0708765A4 (en) * 1993-07-16 1996-06-26 Merck & Co Inc PIPERAZINYLCAMPHER DERIVATIVES SUBSTITUTED AS OXYTOCIN ANTAGONISTS
ATE216580T1 (de) * 1993-07-16 2002-05-15 Merck & Co Inc Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
FR2714378B1 (fr) * 1993-12-24 1996-03-15 Sanofi Sa Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
GB9918684D0 (en) * 1999-08-09 1999-10-13 Novartis Ag Organic compounds
JP4080868B2 (ja) 2000-10-17 2008-04-23 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 医薬として活性なスルファニリド誘導体
GB0115515D0 (en) * 2001-06-25 2001-08-15 Ferring Bv Oxytocin agonisys
GB0116594D0 (en) 2001-07-06 2001-08-29 Cancer Res Ventures Ltd Therapeutic compounds
ES2249636T3 (es) 2001-12-20 2006-04-01 Applied Research Systems Ars Holding N.V. Triazoles como antagonistas de la oxitocina.
EP2402310A1 (en) * 2002-05-24 2012-01-04 Millennium Pharmaceuticals, Inc. CCR9 inhibitors and methods of use thereof
JP4465281B2 (ja) * 2002-12-20 2010-05-19 キャンサー・リサーチ・テクノロジー・リミテッド 治療薬としての4−(1−(スルホニル)−1h−インドール−2−イル)−4−(ヒドロキシ)−シクロヘキサ−2,5−ジエノン化合物およびその類似体
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
FR2880023B1 (fr) 2004-12-23 2007-02-23 Sanofi Aventis Sa Derives de n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine leur preparation et leur application en therapeutique
FR2927625B1 (fr) 2008-02-19 2010-03-12 Sanofi Aventis Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
FR2930249B1 (fr) 2008-04-21 2010-05-14 Sanofi Aventis Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838167A (en) * 1972-08-01 1974-09-24 Lilly Co Eli Process for preparing indoles
US4479963A (en) * 1981-02-17 1984-10-30 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
DE3705934A1 (de) * 1987-02-25 1988-09-08 Nattermann A & Cie Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB8820129D0 (en) * 1988-08-24 1988-09-28 Schering Agrochemicals Ltd Fungicides
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
ES2080922T3 (es) 1996-02-16
FR2665441B1 (fr) 1992-12-04
PT98476B (pt) 1997-10-31
IE73452B1 (en) 1997-06-04
IL99012A (en) 1996-07-23
HU220765B1 (hu) 2002-05-28
ATE129236T1 (de) 1995-11-15
JP3195381B2 (ja) 2001-08-06
PT98476A (pt) 1992-05-29
FR2665441A1 (fr) 1992-02-07
NO912970D0 (no) 1991-07-30
JPH04234361A (ja) 1992-08-24
EP0469984A3 (fr) 1992-03-11
CA2048139C (en) 2002-02-12
AU5047393A (en) 1994-01-13
IE912696A1 (en) 1992-02-12
HU912552D0 (en) 1992-01-28
ZA916031B (en) 1992-04-29
EP0469984B1 (fr) 1995-10-18
HUT59669A (en) 1992-06-29
FI97224B (fi) 1996-07-31
FI97224C (fi) 1996-11-11
NO175254C (no) 1994-09-21
EP0469984A2 (fr) 1992-02-05
KR920002537A (ko) 1992-02-28
IL114934A0 (en) 1995-12-08
NZ239182A (en) 1995-07-26
NO175254B (no) 1994-06-13
AU664491B2 (en) 1995-11-16
IL99012A0 (en) 1992-07-15
KR100211434B1 (ko) 1999-08-02
FI913614A (fi) 1992-02-01
CA2048139A1 (en) 1992-02-01
FI913614A0 (fi) 1991-07-29
AU645585B2 (en) 1994-01-20
DE69113911D1 (de) 1995-11-23
AU8147891A (en) 1992-02-06
DE69113911T2 (de) 1996-03-28

Similar Documents

Publication Publication Date Title
NO912970L (no) Fremgangsmaate for fremstilling av derivater av n-sylfonylindolin.
DE3768689D1 (de) N-substituierte 3,4,5,6-tetrahydrophthalimide und deren vorprodukte.
DE69433984D1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
DE69319925D1 (de) Indol-piperazin-derivate als selektive liganden der 5ht1d und 5ht1b receptoren verwendbar als arzneimittel
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
DK0646110T3 (da) N-substituerede 3-azabicyclo(3.2.0) heptanderivater som neuroleptika
ATE225335T1 (de) Amide derivate als 5-ht1a liganden
ATE212356T1 (de) Carbamoylmethylharnstoffderivate
HUP0001545A2 (hu) Karbonsavészterszármazékok, előállításuk és alkalmazásuk herbicid hatású piridazin-3-on-származékok előállítására
ZA941334B (en) Amide derivative .
GT200000024A (es) Compuestos de 1, 2, 3, 4 - tetrahidro - 1 - naftalenamina utiles en terapia.
CO4750832A1 (es) Nuevos derivados de quinolina
YU47530B (sh) 6-supstituisani-heksahidrobenz cd indoli i postupak za njihovo dobijanje
ECSP961946A (es) Nuevos derivados de quinoleina

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees